Skip to main content
Clinical Trials/NCT05039918
NCT05039918
Unknown
N/A

The Healing Power of Touch: Investigation of a Peripheral Neurological Mechanism for Reducing Pain and Enhancing Neurodevelopmental Outcomes

Liverpool John Moores University1 site in 1 country40 target enrollmentSeptember 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Premature Birth
Sponsor
Liverpool John Moores University
Enrollment
40
Locations
1
Primary Endpoint
Salivary cortisol
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this randomised control trial is to determine the efficacy of CT-optimal touch (gentle stroking at 3cm/s) for newborn's who require a heel prick.

Detailed Description

Newborn infants are subject to several novel experiences that cause physiological, biochemical and behavioural indicators of stress; even routine and common events such as handling, changing a diaper or being bathed can increase salivary cortisol levels. Excluding surgery and mechanical ventilation, the most common procedural pain sources in newborns are heel-lancing and venepuncture. Tactile interventions such as skin to skin care and 'still containment hold' are widely used in clinical care with apparent positive results such as lower mean respiratory heart rate and pain measures, and higher oxygen saturation; yet, dynamic touch interventions have reported to be more beneficial than static touch interventions. A distinct type of nerve fibres, CT (C tactile) afferents, found exclusively in hairy skin, that respond optimally to gentle stroking at a velocity of \~1-10cm/s, are part of a system for processing pleasant and social rewarding touch. CT fibre activation also plays a role in pain inhibition and may be linked to the development of self-regulation, thereby, serving a neuroprotective function for the developing infant brain. Here we will investigate whether tactile stimulation at CT-optimal velocity will reduce biochemical and physiological indicators of stress in infants, as determined by salivary cortisol, heart rate and blood oxygenation levels.

Registry
clinicaltrials.gov
Start Date
September 2021
End Date
March 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The infant is born between 35 and 42 weeks.
  • Require a heel prick
  • Infants may be treated with antibiotics.
  • Infants may be supported with non-invasive respiratory support.
  • Infants may require blood sugar monitoring.
  • Infants may be monitored for jaundice or infection.
  • Written consent has been obtained from the person(s) with parental responsibility.

Exclusion Criteria

  • Have a history of neurological problems.
  • Receiving pharmacological analgesics.
  • Known genetic condition.
  • Breastfed babies
  • Admitted to high dependency or intensive care
  • Invasive respiratory support
  • Receiving parenteral nutrition
  • Has received any treatment for seizures
  • Clinical instability in the judgment of nurses/midwives and paediatricians looking after the baby and mother.

Outcomes

Primary Outcomes

Salivary cortisol

Time Frame: Immediately before heel prick and 20 minutes after

Change between cortisol levels at baseline and 20 minutes after

Secondary Outcomes

  • Heart rate(Baseline, time of event, 20 mins after and 60 minutes after)
  • Blood oxygenation(Baseline, time of event, 20 mins after and 60 minutes after)

Study Sites (1)

Loading locations...

Similar Trials